O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
+12.32%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$5.22B
AUM Growth
+$5.22B
(+97,106%)
Cap. Flow
+$35.6M
Cap. Flow
% of AUM
0.68%
Top 10 Holdings %
Top 10 Hldgs %
34.68%
Holding
137
New
7
Increased
25
Reduced
21
Closed
21
Top Buys
| 1 |
UnitedHealth
UNH
|
$60.1M |
| 2 |
Ionis Pharmaceuticals
IONS
|
$46.3M |
| 3 |
Tenet Healthcare
THC
|
$28.2M |
| 4 |
Vaxcyte
PCVX
|
$27.1M |
| 5 |
Evolent Health
EVH
|
$23.3M |
Top Sells
| 1 |
argenx
ARGX
|
$96M |
| 2 |
Disc Medicine
IRON
|
$72.9M |
| 3 |
Pfizer
PFE
|
$61.8M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
$29.4M |
| 5 |
VRNA
Verona Pharma
VRNA
|
$29.3M |
Sector Composition
| 1 | Healthcare | 98.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Arcus Biosciences
RCUS
$1.13B
| – | – | -303,000 | Closed | -$7.93K |
|
127
Sanofi
SNY
$121B
| – | – | 0 | – | – |
|
128
Vor Biopharma
VOR
$250M
| – | – | -111,808 | Closed | -$445 |
|
|
LENZ
129
LENZ Therapeutics
LENZ
$1.1B
| – | – | -848,412 | Closed | -$2.69K |
|
|
ACHL
130
DELISTED
Achilles Therapeutics plc American Depositary Shares
ACHL
| – | – | -1,463,251 | Closed | -$3.31K |
|
|
JNCE
131
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| – | – | -2,928,900 | Closed | -$6.85K |
|
|
TCDA
132
DELISTED
Tricida, Inc. Common Stock
TCDA
| – | – | -10,280,947 | Closed | -$108K |
|
|
LOGC
133
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
| – | – | -8,466,783 | Closed | -$2.3K |
|
|
LBPH
134
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
| – | – | -113,500 | Closed | -$422 |
|